Related references
Note: Only part of the references are listed.Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
Martin Maron et al.
HEART (2023)
Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy
Nadine Molitor et al.
HEART (2023)
Management of Hypertrophic Cardiomyopathy JACC State-of-the-Art Review
Barry J. Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)
Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: A propensity-matched analysis from a multicenter European registry
Simone Gulletta et al.
HEART RHYTHM (2022)
Spectrum and prevalence of side effects and complications with guideline-directed therapies for congenital long QT syndrome
Katherine Martinez et al.
HEART RHYTHM (2022)
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC)
Katja Zeppenfeld et al.
EUROPEAN HEART JOURNAL (2022)
Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator
Paul Friedman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Perioperative Safety and Early Patient and Device Outcomes Among Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Implantations: A Randomized, Multicenter Trial
Jeff S. Healey et al.
ANNALS OF INTERNAL MEDICINE (2022)
The Guidant Affair: 15 years later
Barry J. Maron et al.
HEART RHYTHM (2021)
Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator
Barry J. Maron et al.
HEART RHYTHM (2021)
2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
Martin K. Stiles et al.
HEART RHYTHM (2020)
Prediction and Prevention of Sudden Death in Young Patients (<20 years) With Hypertrophic Cardiomyopathy
Ethan J. Rowin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Subcutaneous or Transvenous Defibrillator Therapy
Reinoud E. Knops et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Long-Term Outcome in High-Risk Patients With Hypertrophic Cardiomyopathy After Primary Prevention Defibrillator Implants
Ethan J. Rowin et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2020)
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy
Jeffrey A. Towbin et al.
HEART RHYTHM (2019)
Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy
Martin S. Maron et al.
JAMA CARDIOLOGY (2019)
Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy
Barry J. Maron et al.
CIRCULATION RESEARCH (2019)
Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators
Barry J. Maron et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2018)
2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Sana M. Al-Khatib et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Clinical Course and Management of Hypertrophic Cardiomyopathy
Barry J. Maron
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm Implications for Risk Stratification and Management
Ethan J. Rowin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy A Meta-analysis
Sana M. Al-Khatib et al.
JAMA CARDIOLOGY (2017)
Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies
Barry J. Maron et al.
CIRCULATION (2016)
Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure
Lars Kober et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality Shaped by 50 Years of Clinical Research and Practice
Barry J. Maron et al.
JAMA CARDIOLOGY (2016)
Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia An International Task Force Consensus Statement
Domenico Corrado et al.
CIRCULATION (2015)
Ventricular Arrhythmias in the North American Multidisciplinary Study of ARVC Predictors, Characteristics, and Treatment
Mark S. Link et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Risk Stratification and Outcome of Patients With Hypertrophic Cardiomyopathy ≥60 Years of Age
Barry J. Maron et al.
CIRCULATION (2013)
Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator
Raul Weiss et al.
CIRCULATION (2013)
Implantable Cardioverter Defibrillators in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Patient Outcomes, Incidence of Appropriate and Inappropriate Interventions, and Complications
Arend F. L. Schinkel
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2013)
HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes
Silvia G. Priori et al.
HEART RHYTHM (2013)
Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy
Barry J. Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Evolution of the Implantable Cardioverter-Defibrillator From Bullets to BBs
Roger A. Winkle
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
European utilization of the implantable defibrillator: has 10 years changed the 'enigma'?
A. John Camm et al.
EUROPACE (2010)
Unusual failure of a multilumen, small-diameter implantable cardioverter-defibrillator lead
Zaccaria Jalal et al.
HEART RHYTHM (2010)
Review of the Registry's Fourth Year, Incorporating Lead Data and Pediatric ICD Procedures, and Use as a National Performance Measure
Stephen C. Hammill et al.
HEART RHYTHM (2010)
An Entirely Subcutaneous Implantable Cardioverter-Defibrillator
Gust H. Bardy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure
Robert G. Hauser et al.
HEART RHYTHM (2009)
Defibrillator Implantation Early after Myocardial Infarction
Gerhard Steinbeck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events.
Arthur J. Moss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead
Robert G. Hauser et al.
HEART RHYTHM (2007)
Lessons from the failure and recall of an implantable cardioverter-defibrillator
RG Hauser et al.
CIRCULATION (2005)
The effect of cardiac resynchronization on morbidity and mortality in heart failure
JGF Cleland et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure
GH Bardy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Evolution of the implantable cardioverter defibrillator
DS Cannom et al.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2004)
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
SH Hohnloser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators - Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results
MS Wathen et al.
CIRCULATION (2004)
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
MR Bristow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy
A Kadish et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
MADIT II (second Multicenter Automated Defibrillator Implantation Trial) debate - Risk stratification, costs, and public policy
MR Reynolds et al.
CIRCULATION (2003)
Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease - An analysis of patients enrolled in the Multicenter Unsustained Tachycardia Trial
AE Buxton et al.
CIRCULATION (2002)
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction
AJ Moss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest -: The Cardiac Arrest Study Hamburg (CASH)
KH Kuck et al.
CIRCULATION (2000)
Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death
AE Buxton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Canadian implantable defibrillator study (CIDS) - A randomized trial of the implantable cardioverter defibrillator against amiodarone
SJ Connolly et al.
CIRCULATION (2000)
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
BJ Maron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
